Discover
PALI
Palisade Bio, Inc.
1.92
10 x 1.89
1 x 2.12
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
1.93 +0.01 (0.52%)
| Ytd | -18.30% | |
| 1y | 123.26% |
day range
0.53
52 week range
2.86
| Open | Prev Close | 1.92 | Low | High | Mkt Cap | 333.27M | |||
| Vol | 0.00 | Avg Vol | 3.62M | EPS | -1.05 | P/E | -1.83 | Forward P/E | -0.19 |
| Beta | 1.50 | Short Ratio | 0.29 | Inst. Own | 3.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 1.91 | 200-d Avg | 1.91 | 1yr Est | 30.33 |
| Income Statement | |||
| Operating Expenses | 10.75M | ||
| Research and Development Expense | 6.40M | ||
| Selling, General and Administrative Expense | 4.35M | ||
| Operating Income | -10.75M | ||
| Interest Expense | 1000 | ||
| Net Income | -9.60M | ||
| Net Income Common Stock | -9.60M | ||
| Net Income Common Stock (USD) | -9.60M | ||
| Consolidated Income | -9.60M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -9.60M | ||
| Earning Before Interest & Taxes (USD) | -9.60M | ||
| Weighted Average Shares | 209.66M | ||
| Weighted Average Shares Diluted | 209.66M | ||
| Balance Sheet | |||
| Cash and Equivalents | 132.68M | ||
| Cash and Equivalents (USD) | 132.68M | ||
| Current Assets | 133.24M | ||
| Total Assets | 133.32M | ||
| Current Liabilities | 5.62M | ||
| Total Liabilities | 5.95M | ||
| Accumulated Retained Earnings (Deficit) | -162.32M | ||
| Shareholders Equity | 127.36M | ||
| Shareholders Equity (USD) | 127.36M | ||
| Assets Non-Current | 72.00K | ||
| Liabilities Non-Current | 333.00K | ||
| Trade and Non-Trade Payables | 2.70M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 3.13M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -757.00K | ||
| Issuance (Purchase) of Equity Shares | 3.20M | ||
| Issuance (Repayment) of Debt Securities | -71.00K | ||
| Net Cash Flow from Operations | -3.89M | ||
| Share Based Compensation | 4.30M | ||